Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 14Unknown 6Not yet recruiting 4Recruiting 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 4OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 4Tumor-Agnostic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Unresectable Stage III NSCLC 1Neoplasms, Unknown Primary 1Esophageal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Unknown × CP protocol × Clear all
NCT04982549 2021-08-06

A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

Shandong Cancer Hospital and Institute

Phase 2 Unknown
35 enrolled
Thoracic

Unresectable Stage III NSCLC

NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01872403 2013-06-07

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage â…¡ B and IIIA Squamous Cell Carcinoma of the Lung

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Unknown
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01527864 2012-02-07

Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer

Protgen Ltd

Phase 2 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Zhejiang Cancer Hospital

Phase 2 Unknown
134 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00894569 2009-05-14

PACET-CUP

Heidelberg University

Phase 2 Unknown
150 enrolled
Tumor-Agnostic

Carcinoma, Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡